601 related articles for article (PubMed ID: 36964247)
1. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysis.
Dunder L; Salihovic S; Varotsis G; Lind PM; Elmståhl S; Lind L
Environ Int; 2023 Nov; 181():108250. PubMed ID: 37832261
[TBL] [Abstract][Full Text] [Related]
3. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
[TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
7. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
[TBL] [Abstract][Full Text] [Related]
8. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
[TBL] [Abstract][Full Text] [Related]
9. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
[TBL] [Abstract][Full Text] [Related]
12. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
Ojo AF; Xia Q; Peng C; Ng JC
Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
[TBL] [Abstract][Full Text] [Related]
14. Exposure to novel and legacy per- and polyfluoroalkyl substances (PFASs) and associations with type 2 diabetes: A case-control study in East China.
Han X; Meng L; Zhang G; Li Y; Shi Y; Zhang Q; Jiang G
Environ Int; 2021 Nov; 156():106637. PubMed ID: 33993001
[TBL] [Abstract][Full Text] [Related]
15. Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population.
Salihovic S; Lind L; Larsson A; Lind PM
Environ Int; 2020 Dec; 145():106099. PubMed ID: 32916415
[TBL] [Abstract][Full Text] [Related]
16. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
[TBL] [Abstract][Full Text] [Related]
17. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
Kang H; Kim SH
Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
[TBL] [Abstract][Full Text] [Related]
18. Exposure to isomers of per- and polyfluoroalkyl substances increases the risk of diabetes and impairs glucose-homeostasis in Chinese adults: Isomers of C8 health project.
Zeeshan M; Zhang YT; Yu S; Huang WZ; Zhou Y; Vinothkumar R; Chu C; Li QQ; Wu QZ; Ye WL; Zhou P; Dong P; Zeng XW; Hu LW; Yang BY; Shen X; Zhou Y; Dong GH
Chemosphere; 2021 Sep; 278():130486. PubMed ID: 34126693
[TBL] [Abstract][Full Text] [Related]
19. Associations between per- and polyfluoroalkyl substances, liver function, and daily alcohol consumption in a sample of U.S. adults.
Ma X; Fisher JA; VoPham T; Vasiliou V; Jones RR
Environ Res; 2023 Oct; 235():116651. PubMed ID: 37451576
[TBL] [Abstract][Full Text] [Related]
20. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
